| View web version » |
|
|
Assessing What’s Important to Patients |
|
For too long, traditional definitions of value have failed to adequately incorporate patient perspectives on value. This is why FasterCures partnered with Avalere Health and a multi-stakeholder Steering Committee to develop the first patient-centered value framework. The recently released Patient Perspective Value Framework version 1.0 incorporates measures of benefits and costs in the context of what matters to patients to assess the value of health-care treatment options. Read more in the full report and article in Health Affairs Blog
|
|
| PROGRAM HIGHLIGHTS |
FasterCures is Working to Improve Understanding about Health Data
FasterCures is developing a tool to help the 41 percent of Americans who have never viewed their health data understand the power of health data access. With support from the Patient-Centered Outcomes Research Institute (PCORI) Eugene Washington PCORI Engagement Award program, FasterCures has launched a project called Health Data Basics to help people understand what makes up their health data. Using information gathered through an anonymous survey and interviews with subject matter experts, we will work with Involution Studios to design a tool prototype to inform people about health data access and use. Learn more about this new project on our blog. |
|
|
|
FasterCures Urges Caution before Moving Forward with FDA Office of Patient Affairs
On June 12, FasterCures submitted comments in response to the U.S. Food and Drug Administration’s (FDA) proposal to create an Office of Patient Affairs. In our letter, we point out that while FasterCures has long supported efforts to enhance and improve the science of patient input, we are unable to offer our support for establishing the office at this time without more clarity from FDA as to how this office will be resourced, how it will interact with FDA’s medical product review centers, and how it will influence existing patient engagement efforts. Instead, we urge FDA to explore ways to improve or enhance existing structures and offices at FDA, or to provide more clarity regarding the structure and objectives of the Office of Patient Affairs. Read our full comments for more information. |
|
Your Guide to Understanding User Fee Agreements
FasterCures advocates for the timely reauthorization of the FDA's user fee agreements with industry, ensuring that FDA has the resources it needs to execute its important public health mission. These agreements include commitments to advance the science of patient input, while also providing resources to help address FDA’s persistent challenge of recruiting and maintaining a highly qualified workforce to implement those commitments. To dive deeper into the Prescription Drug User Fee Act VI and Medical Device User Fee Amendments IV, read FasterCures’ position on each commitment letter. And check out our blog for three reasons why we will be closely monitoring the reauthorization process.
|
|
| BUZZWORTHY |
|
Patients Count Case File: American Heart Association Pioneering Long-Term Engagement with “My Research Legacy”, by Kim McCleary, Managing Director
Health Citizenship: The Nexus of Data, Technology, and Research, by Colin Ward, Senior Associate
Risk vs. Reward: The Growing Cyberthreat to Interconnected Health Care, by Mark Williams, Associate
Cracking the Code of Addiction and Mental Health, by Taylor Cusher, Senior Associate
FasterCures Congratulates Scott Gottlieb on Confirmation as FDA Commissioner
17 Minutes: Countdown to a New Vision for Healthcare, by Kim McCleary, Managing Director, as seen in LinkedIn Pulse
How Tech Disruption Can Start to Hit Biomedical Research at a Faster Rate, by Margaret Anderson, as seen in LinkedIn Pulse
|
|
|
|
| ©2017 Milken Institute | 1101 New York Avenue, NW | Suite 620 | Washington, DC | +1 202 336 8900 |
|
|
|